Literature DB >> 15828923

Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.

Akira Andoh1, Tomoyuki Tsujikawa, Osamu Inatomi, Yasuyuki Deguchi, Kazunori Hata, Katsuyuki Kitoh, Masaya Sasaki, Keiichi Mitsuyama, Yoshihide Fujiyama.   

Abstract

To elucidate the molecular mechanisms involved in the therapeutic effects of granulocyte/monocyte adsorption apheresis, changes were investigated in the cytokine responses of peripheral blood mononuclear cells (PBMC) before and after granulocyte/monocyte adsorptive apheresis in ulcerative colitis (UC) patients. Four patients with active UC were enrolled. All patients responded to granulocyte/monocyte adsorptive apheresis. A total of 20 sessions of four patients were analyzed. Peripheral blood mononuclear cells were isolated from peripheral venous blood within 5 min before and after each session of granulocyte/monocyte adsorptive apheresis. The cells were stimulated with interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha for 24 h, and the secreted IL-8 and IL-6 levels were determined by enzyme-linked immunosorbent assay (ELISA). IL-1beta-induced IL-8 and IL-6 secretion was significantly decreased after granulocyte/monocyte adsorptive apheresis. TNF-alpha-induced IL-8 secretion was also significantly decreased after apheresis, but there was no significant difference in TNF-alpha-induced IL-6 secretion (P = 0.052). In conclusion, granulocyte/monocyte adsorptive apheresis down-regulates the IL-1beta- and TNF-alpha-induced inflammatory responses in PBMC. The induction of hyporesponsiveness to pro-inflammatory cytokines may be an important factor mediating the clinical effects of granulocyte/macrophage adsorptive apheresis in UC patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15828923     DOI: 10.1111/j.1774-9987.2005.00229.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  6 in total

1.  Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.

Authors:  Yoko Yokoyama; Ken Fukunaga; Yoshihiro Fukuda; Katsuyuki Tozawa; Koji Kamikozuru; Kunio Ohnishi; Takeshi Kusaka; Tadashi Kosaka; Nobuyuki Hida; Yoshio Ohda; Hiroto Miwa; Takayuki Matsumoto
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

2.  Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.

Authors:  Takayuki Matsumoto; Ken Fukunaga; Koji Kamikozuru; Katsutoshi Tozawa; Yoko Yokoyama; Takeshi Kusaka; Kunio Onishi; Hiroto Miwa; Shiro Nakamura
Journal:  Transfus Med Hemother       Date:  2007-12-21       Impact factor: 3.747

3.  Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Authors:  Shin-ichiro Takeda; Toru Sato; Tatsuro Katsuno; Tomoo Nakagawa; Yoshiko Noguchi; Osamu Yokosuka; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-11-12       Impact factor: 3.199

Review 4.  Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.

Authors:  Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

5.  A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis.

Authors:  Chiharu Tominaga; Masaaki Yamamoto; Yasutomo Imai; Kiyofumi Yamanishi
Journal:  Case Rep Dermatol       Date:  2015-02-21

6.  Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.

Authors:  Asami Fujii; Yoko Mizutani; Yuki Hattori; Tomoko Takahashi; Hidenori Ohnishi; Shozo Yoshida; Mariko Seishima
Journal:  Case Rep Dermatol       Date:  2017-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.